Research map: Efficacy and mechanism of the anti-CD38 monoclonal antibody Daratumumab against primary effusion lymphoma

Back to the article

Papers in this map

  1. Complement and its role in innate and adaptive immune responses · Jason Dunkelberger · 2009 · 2001 citations · Cited by this paper
  2. Malignancy and viral infections in Sub-Saharan Africa: A review · Mahamadou Diakité · 2023 · 31 citations · Cites this paper
  3. HBO1 suppresses anti-tumor immunity of CD8⁺ T Cells in thyroid cancer by recruiting BRD4 to regulate VTCN1 expression · 2026 · Related
  4. Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors · Michel de Weers · 2010 · 1045 citations · Cited by this paper
  5. Immunotherapy for KSHV-associated diseases · Kathryn Anne Lurain · 2022 · 22 citations · Cites this paper
  6. Conserved minimal CD8 cytotoxic immune-state unit in an IL18R1-associated immune program in hepatocellular carcinoma · 2026 · Related
  7. Antigen-specific human antibodies from mice comprising four distinct genetic modifications · Nils Carl Lønberg · 1994 · 398 citations · Cited by this paper
  8. 99mTc-CD3813: A Nanobody-Based Single Photon Emission Computed Tomography Radiotracer with Clinical Potential for Myeloma Imaging and Evaluation of CD38 Expression · Linqing Shi · 2022 · 19 citations · Cites this paper
  9. Impact of neck nodal yield on immune checkpoint inhibitor outcome after recurrence in head and neck squamous cell carcinoma · 2026 · Related
  10. The Therapeutic CD38 Monoclonal Antibody Daratumumab Induces Programmed Cell Death via Fcγ Receptor–Mediated Cross-Linking · Marije B. Overdijk · 2016 · 298 citations · Cited by this paper
  11. Modern Approach to Manage Patients With Kaposi Sarcoma · Thomas Bettuzzi · 2025 · 15 citations · Cites this paper
  12. Preclinical efficacy of iPSC-derived MUC1-targeted CAR-NK cells against esophageal squamous cell carcinoma · 2026 · Related
  13. Untitled · Cited by this paper
  14. Elotuzumab, a potential therapeutic humanized anti-SLAMF7 monoclonal antibody, enhances natural killer cell-mediated killing of primary effusion lymphoma cells · Jutatip Panaampon · 2022 · 13 citations · Cites this paper
  15. Survival outcomes of conversion curative therapy following atezolizumab–bevacizumab in advanced hepatocellular carcinoma · 2026 · Related
  16. Untitled · Cited by this paper
  17. Daratumumab induces cell-mediated cytotoxicity of primary effusion lymphoma and is active against refractory disease · Prabha Shrestha · 2023 · 12 citations · Cites this paper
  18. Integrative single-cell and multi-omics analysis of ZBTB21-mediated serine metabolism in colorectal cancer: from metabolic reprogramming to immune microenvironment modulation · 2026 · Related
  19. Untitled · Cited by this paper
  20. Trastuzumab, a monoclonal anti-HER2 antibody modulates cytotoxicity against cholangiocarcinoma via multiple mechanisms · Jutatip Panaampon · 2024 · 10 citations · Cites this paper
  21. Untitled · Cited by this paper
  22. Promising immunotherapeutic approaches for primary effusion lymphoma · Jutatip Panaampon · 2024 · 7 citations · Cites this paper
  23. Untitled · Cited by this paper
  24. Stealth designs to overcome allorejection in engineered cell therapy · Yan-Ruide Li · 2026 · 5 citations · Cites this paper
  25. Untitled · Cited by this paper
  26. Anti-CD47 tri-specific killer engager enhances NK cell cytotoxicity against lung cancer · Chutipa Chiawpanit · 2025 · 2 citations · Cites this paper
  27. Untitled · Cited by this paper
  28. Review of daratumumab efficacy in all monoclonal gammopathies and other diseases and our experience with daratumumab, lenalidomide and dexamethasone therapy in 74 patients · Zdeněk Adam · 2022 · Cites this paper
  29. Untitled · Cited by this paper
  30. Human herpes virus 8-related illness: still with us · Ian John Woolley · 2022 · Cites this paper
  31. Untitled · Cited by this paper
  32. Transgenic expression of human signal regulatory protein alpha (SIRPα) in BALB/c Rag2 null /Jak3 null immunodeficient mice improves human lymphoma xenograft via reduction of phagocytosis · Jutatip Panaampon · 2026 · Cites this paper
  33. Untitled · Cited by this paper
  34. Transgenic expression of human signal regulatory protein alpha (SIRPα) in BALB/c Rag2null/Jak3null immunodeficient mice enhances human lymphoma xenografts by reducing phagocytosis · Jutatip Panaampon · 2026 · Cites this paper
  35. Untitled · Cited by this paper
  36. Case Report: Synchronous Manifestations of Kaposi Sarcoma Herpesvirus‐Associated Disorders · Kandice Roberts · 2025 · Cites this paper
  37. Untitled · Cited by this paper
  38. Absence of CD38 expression in mantle cell lymphoma correlates with distinct pathological and genetic features · Sara Abu Mehsen · 2026 · Cites this paper
  39. Untitled · Cited by this paper

Source: OpenAlex (CC0)